Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

SSRIs And Suicide To Be Discussed By Pediatric Advisory Cmte. In September

Executive Summary

FDA's Pediatric Advisory Committee will hold its first meeting in September as a joint session with the Psychopharmacologic Advisory Committee

You may also be interested in...



Duragesic “Black Box” Should Include Pediatric Death Warning – Cmte.

Enhanced Duragesic "black box" warnings on pediatric deaths are recommended by FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee

Duragesic “Black Box” Should Include Pediatric Death Warning – Cmte.

Enhanced Duragesic "black box" warnings on pediatric deaths are recommended by FDA's Pediatric Subcommittee of the Anti-Infective Drugs Advisory Committee

Antidepressant Warnings On Pediatric Suicide Need Immediate Strengthening

Strengthened warnings about the risk of suicide ideation and attempts among children taking antidepressant medications should be communicated to physicians and consumers as soon as possible, a joint FDA advisory committee told the agency Feb. 2

UsernamePublicRestriction

Register

PS044220

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel